| 000 | 01437cam a2200265 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030816.0 | ||
| 008 | 130401s2011 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aGift | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.34.M.Sc.2011.Sh.N | ||
| 100 | 0 | _aShahir Ashraf Wagdy Aziz | |
| 245 | 1 | 0 |
_aNovel delivery of oseltamivir phosphate dry powder inhalation-formulation and in-vitro characterization / _cShahir Ashraf Wagdy Aziz ; Supervised Hanan M. Ellaithy |
| 260 |
_aCairo : _bShahir Ashraf Wagdy Aziz , _c2011 |
||
| 300 |
_a111LEaves : _bcharts , facsimiles ; _c30cm |
||
| 502 | _aThesis (M.Sc.) - German University - Faculty of Postgraduate Studies and Scientific Research - Department of Pharmacology and Toxicology | ||
| 520 | _aOseltamivir phosphate (OP) is an antiviral drug available only as oral therapy for the treatment of Influenza . The aim of this work is to formulate OP as a dry powder inhalation (DPI) using a novel developed inhaler device (UNI-Haler) for faster targeting and more efficient therapy . Micronized (0.5-5om) and milled (17-45om) Lactose , Trehalose , Mannito and Glucose were used as inert carriers for the preparation of OP DPI formulations | ||
| 700 | 0 |
_aHanan Mohamed Ellaithy , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aFatma _eCataloger |
||
| 905 |
_aNazla _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c42382 _d42382 |
||